IntronA

Medicinal product

(Invented) name

IntronA

Active substance (s)

Interferonas alfa-2b

Strength

3 mln. TV/0,5 ml

Pharmaceutical form

injekcinis ar infuzinis tirpalas

Route (s) of administration

leisti į veną, leisti po oda

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L03AB05, Interferon alfa-2b

Marketing authorisation holder

Merck Sharp & Dohme B.V., Nyderlandai

Date of authorisation

2000-03-09

Date of renewal

Documents

Search in EMA Europe

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Solution for injection or infusion	0.5 ml
Interferonas alfa-2b	3 mln. TV

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
25971	28563	1028563	flakonas	0,5 ml N1		Receptinis	EU/1/99/127/011	Netiekiama	-	-	No	-	-
25972	28564	1028564	flakonas	0,5 ml, injekcinis švirkštas, injekcinė adata ir tamponas N1		Receptinis	EU/1/99/127/012	Netiekiama	-	-	No	-	-
25973	28565	1028565	flakonas	0,5 ml, injekcinis švirkštas, injekcinė adata ir tamponas N6		Receptinis	EU/1/99/127/013	Netiekiama	-	-	No	-	-
25974	28566	1028566	flakonas	0,5 ml, injekcinis švirkštas, injekcinė adata ir tamponas N12		Receptinis	EU/1/99/127/014	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2021-12-01	Išregistruotas
2000-03-09	Registruotas